Chemexpress(SH:688131) Zheng Quan Zhi Xing·2025-07-07 11:12Core Viewpoint - The legal opinion letter issued by Deheng Shanghai Law Firm confirms that the procedures for the upcoming shareholders' meeting of Shanghai Haoyuan Pharmaceutical Co., Ltd. comply with relevant laws and regulations, ensuring the legitimacy of the meeting and its resolutions [1][4][10]. Group 1: Meeting Procedures - The fourth board meeting of the company was held on June 18, 2025, where the decision to convene the shareholders' meeting was made [4]. - The notice for the shareholders' meeting was published on June 20, 2025, detailing the time, location, agenda, and registration methods, with a record date set for July 1, 2025 [4][5]. - The meeting will be conducted using a combination of on-site and online voting methods, with specific time slots allocated for each voting method [5][10]. Group 2: Qualifications of Participants - The shareholders' meeting is convened by the company's board of directors, which is authorized to do so under the Company Law and the company's articles of association [5][6]. - A total of 75 shareholders and representatives attended the meeting, representing 105,439,641 shares with voting rights, which is a significant portion of the total voting shares [5][6]. - All attending shareholders provided valid identification, and the qualifications of online voters were verified by the Shanghai Stock Exchange's information company [6][10]. Group 3: Voting Procedures and Results - Voting was conducted through both written and online methods, with the counting and monitoring of votes carried out by the lawyers, supervisors, and shareholder representatives [6][10]. - The resolutions passed during the meeting included the cancellation of the supervisory board and amendments to the company's articles of association, with significant support from the voting shareholders [8][9]. - The voting results showed overwhelming approval for the proposed resolutions, indicating strong shareholder support for the company's governance changes [8][9].